ABBV AbbVie PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: ABBV
- PE Ratio
As at Nov 6, 2025, the ABBV stock has a PE ratio of 164.69. This is based on the current EPS of $1.33 and the stock price of $219.04 per share. An increase of 55% has been seen in the P/E ratio compared to the average of 106.2 of the last 4 quarters.
ABBV PE ratio history
The mean historical PE ratio of AbbVie over the last ten years is 35.62. The current 164.69 PE ratio is comparable to the historical average. Over the past ten years, ABBV's PE ratio was at its highest in the Sep 2025 quarter at 174.09, with a price of $231.54 and an EPS of $1.33. The Mar 2020 quarter recorded the bottom point at 13.44, with a price of $76.19 and an EPS of $5.67.
AbbVie PE ratio by year
Maximum annual increase: 187.98% in 2014
Maximum annual decrease: -68.09% in 2015
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 74.04 | 30.42% | $177.7 | $2.4 |
| 2023 | 56.77 | 133.62% | $154.97 | $2.73 |
| 2022 | 24.3 | 16.27% | $161.61 | $6.65 |
| 2021 | 20.9 | -46.75% | $135.4 | $6.48 |
| 2020 | 39.25 | 134.89% | $107.15 | $2.73 |
| 2019 | 16.71 | -33.48% | $88.54 | $5.3 |
| 2018 | 25.12 | -14.03% | $92.19 | $3.67 |
| 2017 | 29.22 | 70.28% | $96.71 | $3.31 |
| 2016 | 17.16 | -8.77% | $62.62 | $3.65 |
| 2015 | 18.81 | -68.09% | $59.24 | $3.15 |
| 2014 | 58.95 | 187.98% | $65.44 | $1.11 |
| 2013 | 20.47 | N/A | $52.81 | $2.58 |
| 2012 | N/A | N/A | N/A | $3.35 |
| 2011 | N/A | N/A | N/A | $2.18 |
| 2010 | N/A | N/A | N/A | $2.65 |
AbbVie PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2025 | 174.09 | 97.9% | $231.54 | $1.33 |
| Jun 2025 | 87.97 | -0.91% | $185.62 | $2.11 |
| Mar 2025 | 88.78 | 19.91% | $209.52 | $2.36 |
| Dec 2024 | 74.04 | 7.98% | $177.7 | $2.4 |
| Sep 2024 | 68.57 | 19.94% | $197.48 | $2.88 |
| Jun 2024 | 57.17 | 5.79% | $171.52 | $3 |
| Mar 2024 | 54.04 | -4.81% | $182.1 | $3.37 |
| Dec 2023 | 56.77 | 39.38% | $154.97 | $2.73 |
| Sep 2023 | 40.73 | 47.52% | $149.06 | $3.66 |
| Jun 2023 | 27.61 | -26.2% | $134.73 | $4.88 |
| Mar 2023 | 37.41 | 53.95% | $159.37 | $4.26 |
| Dec 2022 | 24.3 | 36.36% | $161.61 | $6.65 |
| Sep 2022 | 17.82 | -17.5% | $134.21 | $7.53 |
| Jun 2022 | 21.6 | -6.86% | $153.16 | $7.09 |
| Mar 2022 | 23.19 | 10.96% | $162.11 | $6.99 |
ABBV Price vs fair value
ABBV average PE ratio chart
ABBV's current P/E ratio is above the 3, 5 and 10-year historical averages.
PE comparison
With a P/E of 164.69, ABBV is above the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 24.68, AbbVie's P/E is 567% higher.
ABBV PE vs peers
ABBV's PE ratio is higher than its peer stocks LLY and AZN. AbbVie's current PE ratio of 164.69 is comparable to the average of its peer group, which is 25.75.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BIIB Biogen Inc | 14.26 | $22.99B |
| PFE Pfizer Inc | 14.45 | $141.29B |
| BMY Bristol Myers Squibb Co | 15.7 | $94.93B |
| AMGN Amgen Inc | 24.22 | $169.94B |
| GILD Gilead Sciences Inc | 24.44 | $153.12B |
| AZN Astrazeneca plc | 31.26 | $259.69B |
| NBIX Neurocrine Biosciences Inc | 35.92 | $15.43B |
| LLY ELI LILLY & Co | 45.75 | $886.24B |
| ABBV AbbVie Inc | 164.69 | $387.13B |
Frequently asked questions
What is AbbVie's PE ratio?
As of Nov 6, 2025, ABBV stock has a price to earnings ratio of 164.69.
What is the 3-year average PE ratio for AbbVie (ABBV)?
The average PE ratio for ABBV stock over the past 3 years is 65.96.
What is the 5-year average PE ratio for AbbVie (ABBV)?
The average PE ratio for ABBV stock over the past 5 years is 50.49.
What is the highest PE ratio for ABBV?
Over the last ten years, the quarterly PE ratio reached a historic high of 174.09 in the Sep 2025 quarter.
How does the current PE ratio for ABBV compare to its historical average?
ABBV's current price to earnings ratio is 362% above its 10-year historical average.
Why is AbbVie's PE ratio so high?
A company with a higher PE ratio may indicate that the market has higher growth expectations for the company's future earnings or profitability.
How is ABBV's PE ratio calculated (AbbVie PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Nov 6, 2025), AbbVie's stock price is $219.04. The earnings per share for the trailing twelve months (TTM) ending Sep 2025 is $1.33. Therefore, AbbVie's P/E ratio for today is 164.69. PE RATIO(164.69) = STOCK PRICE($219.04) / TTM EPS($1.33)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.